Advancing Breast Cancer Treatment: Harnessing the Potential of Diverse Inorganic Nanoparticles

Abstract

Nanotechnology provides promising avenues for diagnostics, tumor imaging, and targeted drug delivery in breast cancer treatment. This article examines the potential of inorganic nanoparticles in breast cancer theragnosis, specifically Supramagnetic nanoparticles, gold nanoparticles, and quantum dots. It applies a scoping review approach to address the existing challenges and prospects of nanotechnology in managing breast cancer and to propose directions for future research. The findings from the review suggest that critical issues such as biosafety concerns, biocompatibility issues, and potential toxicity must be addressed to ensure the clinical translation of nanoparticle-based therapies. Furthermore, the article underscores the importance of integrating comparative studies and graphical representations to thoroughly analyze current advancements in nanoparticle-mediated breast cancer therapies. The potential of Supramagnetic and gold nanoparticles and quantum dots in revolutionizing breast cancer management is highlighted, offering personalized and effective treatment approaches. The article contributes to the literature on breast cancer theragnosis by addressing related challenges, analyzing comparative studies, and suggesting future research directions.